Formation Bio
Work Here?
About
Company Stage
Series D
Employees
51-200
Industries
Biotechnology, Healthcare
Total Funding
$515.8M
Headquarters
N/A
Founded
N/A
Simplify's Take
What believers are saying
- The recent $372M Series D funding will significantly bolster Formation Bio's expansion and product development efforts.
- Collaborations with industry leaders like Sanofi and OpenAI could revolutionize drug discovery and development, enhancing the company's market position.
- Formation Bio's innovative approach to clinical trials promises more efficient and faster drug development, potentially leading to quicker market entry and higher revenue.
What critics are saying
- The high dependency on AI and technology platforms may pose risks if these technologies fail to deliver as expected.
- The competitive nature of the pharmaceutical industry means that Formation Bio must continuously innovate to maintain its edge.
What makes Formation Bio unique
- Formation Bio leverages a tech-driven platform to optimize clinical drug development, unlike traditional pharmaceutical companies that rely on conventional methods.
- Their strategic partnerships with AI leaders like OpenAI and pharmaceutical giants such as Sanofi set them apart in the competitive landscape.
- Formation Bio's focus on acquiring and accelerating the development of clinical-stage drugs enables faster access to new treatments for patients.
Growth & Insights
Headcount
6 month growth
↑ 3%1 year growth
↑ 7%2 year growth
↑ 22%Formation Bio is Hiring for 0 Jobs on Simplify!
Find jobs on Simplify and start your career today
💡
We update Formation Bio's jobs every 8 hours, so check again soon! Browse all jobs →